Welcome to SGS. Confirm your location for an enhanced experience:
Contact

What are you looking for?

Bulk Harvest

Use the minimum volume of required assays to meet regulatory requirements.

The bulk harvest is a critical stage of any manufacturing process. It is essential that, during this stage, you retain as much of your material as possible, so you can meet regulatory requirements. At SGS, our specialists will work closely with you and your team so you can be sure you are using the minimum volume of required assays.

Services our biosafety team can offer

Microbial contaminants:

  • Mycoplasma via culture and quantitative polymerase chain reaction (qPCR) (USP 63 Phar.Eur.2.6.7)
  • Mycobacteria via culture and validated quantitative polymerase chain reaction (qPCR)
  • Spiroplasma
  • Sterility

Adventitious virus detection:

  • In vitro cell culture assays
  • Hemadsorption and hemagglutination

Specific virus detection:

  • >300 GMP validated virus specific quantitative polymerase chain reaction (qPCR) assays

Identity of control cells:

  • Random amplified polymorphic DNA (RAPD)
  • Nucleic acid testing (NAT)

Retrovirus detection:

  • Fluorescent product enhanced reverse transcriptase (F-PERT) and quantitative real time fluorescent product enhanced reverse transcriptase (Q-PERT)
  • Transmission electron microscopy
  • Infectious retroviruses/Mus-Dunni/HEK293 cocultivation

Why work with SGS?

Central Lab Services

Scientific expertise

· Our scientists pioneered biosafety testing in the 1990s

· They have spent over 25 years working together as a cohesive group to develop, validate and run GMP
lot release assays

· Our extensive expertise has contributed to our being recognized as a world leader in
biopharmaceutical testing services
SGS Glasgow

A recognized team of experts

· Pioneered real-time PCR and PERT technology for biologics testing

· The Medicine Maker 2015 and 2016 – Top 100 Most Influential People in Drug Development and
Manufacturing

· Scottish Life Sciences 2023 Leadership Award Winner

· US Pharm. Panel of Experts – Viral Vaccines and Cell Banking
Three Scientists Working in Laboratory

Quality

· Multiple successful audits by large pharma and experienced biotechs, including the FDA

· GMP CoAs or final reports – 10+ pages providing detailed info on sample prep, method, validity criteria, results/conclusion, audit steps

· Reports are templated and carefully audited to ensure no errors
Contact us to further discuss your requirements for GMP bulk harvest testing.